Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(14 sites)
Australia
Paratus Clinical Research - Canberra Trial Clinic, Belconnen, Australian Capital Territory Paratus Clinical Brisbane Pty Ltd, Albion, Brisbane Paratus Clinical Research Western Sydney, Blacktown, New South Wales Paratus Clinical Research Central Coast, Kanwal, New South Wales Cornerstone Centre for Clinical Research, Coorparoo, Queensland CMAX Clinical Research Pty Ltd, Adelaide, South Australia Paratus Clinical Research Melbourne, Melbourne, Victoria New Zealand
Momentum Clinical Research Pukekohe, Pukekohe, Auckland Momentum Clinical Research Dunedin, Dunedin, Otago Pacific Clinical Research Network-Tasman, Nelson, Tasman District Medical Research Institute of New Zealand, Newtown, Wellington Region Pacific Clinical Research Network-Wellington, Upper Hutt, Wellington Region Momentum Clinical Research Kapiti, Waikanae, Wellington Region Pacific Clinical Research Network-West Auckland, Auckland